Summary of Kansas City Attorney General’s Report
BY CARL HENEGHAN JULY 10, 2024 CCINES
We’ve extracted the main points from the Kansas City Attorney General’s legal report on the case against Pfizer that we first mentioned in Due Process—all quotes are taken verbatim.Five Pages of What Pfizer illegally did, only posting 21/2
This is a lengthy post, and we’d recommend having an anger management strategy to hand while reading. If you are making a comment, use the numbering to highlight which points you are referring to, and do let us know if we’ve missed anything.
-
Pfizer misled the public.
• In May 2021, Pfizer advertised to Kansans on Facebook about its “life-saving vaccines” and its “cures.” Upon information and belief, Pfizer intended for Kansans to think of its Covid-19 vaccine when it discussed “life-saving vaccines” and “cures.” Pfizer ran three different ads between May 4, 2021 and June 1, 2021 that received 165,000 to 190,000 impressions.”
• Pfizer received emergency use authorization for its Covid-19 vaccine inindividuals 16 years of age and older on December 11, 2020.
• Pfizer received FDA approval on August 23, 2021. From 2021 to 2023, Pfizer received emergency use authorizations in children from six months to 15 years of age.
-
Pfizer used confidentiality agreements to conceal critical data relating to the safety and effectiveness of its Covid-19 vaccine.
• Pfizer effectively had a veto over the federal government’s communications.
-
Pfizer used its confidentiality agreements with the US government and others to conceal, suppress, and omit material facts relating to Pfizer’s Covid-19 vaccine, including the safety and efficacy of the vaccine.
-
Pfizer used an extended study timeline to conceal critical data – the study was repeatedly delayed.
• Pfizer planned to provide researchers with access to patient-level data and fullclinical study reports 24 months after study completion. Protocol C4591001
• Pfizer estimated that it would complete the study by January 27, 2023, but that estimated date fell back to February 2024 because of a late vaccination of a single study participant (out of 44,000 participants).
• Pfizer’s control of the data allowed the company to selectively publish results for which the underlying data could not be independently evaluated.
-
Pfizer says it will make data from vaccine trials approved in the US available 18 months after the primary study completion date. Pfizer, Data Access Requests.
• Upon information and belief, Pfizer has still not made its complete study data available to researchers.
-
The FDA did not make the safety and effectiveness data for Pfizer’s Covid-19 vaccine immediately available.
• The FDA denied expedited processing of PHMPTA’s FOIA request and claimed inlitigation that it would take 55 years—until 2076
• In January 2022, a federal judge rejected the FDA’s proposed production of 500 pages per month and ordered the FDA to instead produce 55,000 pages per month
-
Pfizer destroyed the vaccine control group.
• Pfizer planned to follow Covid-19 vaccine study participants, both vaccine andplacebo recipients for 24 months to monitor the safety and effectiveness of its vaccine.
• Once the FDA approved Pfizer’s Covid-19 vaccine through an emergency use authorization in December 2020, Pfizer unblinded the study participants and offered vaccine placebo recipients the option to receive the Pfizer Covid-19 vaccine.
• Only 1,544 placebo participants had not received the vaccine as of March 13, 2021, just 7% of the original placebo group.
-
In its press release announcing emergency use authorization of its Covid-19 vaccine, Pfizer did not disclose that it had excluded immunocompromised individuals from its Covid-19 vaccine trials.
• Instead, in “Important Safety Information” in its press release, Pfizer noted that
• “[i]mmunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the Pfizer BioNTech COVID-19 Vaccine.”
-
Pfizer knew its Covid-19 vaccine was connected to serious adverse events, including myocarditis and pericarditis.
• Pfizer maintained its own adverse events database that “contain[ed] cases of [adverse events (AEs)] reported spontaneously to Pfizer, cases reported by the health authorities, cases published in the medical literature, cases from Pfizer-sponsored marketing programs, non-interventional studies, and cases of serious AEs reported from clinical studies regardless of causality assessment.”
• Upon information and belief, Pfizer’s adverse events database contained moreadverse event data than VAERS because it included both information in VAERS and information not in VAERS….
https://brownstone.org/articles/summary-of-kansas-city-attorney-generals-report/